Doctor profile · Federal record
Dr. WINSTON CHUA, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hematology & Oncology Physician · PADUCAH, KY
- NPI 1013923846
- Accepts Medicare
- MIPS 94.8 / 100 · 2023
- 35 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2603 KENTUCKY AVE, SUITE 403
PADUCAH, KY 420033814
(270) 444-3930
fax (270) 442-5284
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- December 2, 2020
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Kentucky #41261 · Alabama #22568
- Medicaid (2)
- AL #009933001 · AL #009982110
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1013923846. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,214
Distinct HCPCS
5
Medicare allowed
$159,660
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 924 | 292 | $120 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 190 | 98 | $169 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 61 | 61 | $208 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 24 | 13 | $76 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 15 | 14 | $125 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 242. This provider delivers 5.0× the peer median.Open Payments
Industry payments received
All-time total
$515
Transactions
25
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $95.14 | |
| Astellas Pharma US Inc | 3 | $61.47 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $52.23 | |
| Tempus AI, Inc | 2 | $46.90 | |
| PFIZER INC. | 2 | $39.00 | |
| Pharmacosmos Therapeutics Inc. | 2 | $37.66 | |
| ABBVIE INC. | 2 | $33.61 | |
| Daiichi Sankyo Inc. | 1 | $29.48 | |
| Eisai Inc. | 1 | $21.49 | |
| GENZYME CORPORATION | 1 | $21.19 | |
| BeiGene USA, Inc. | 1 | $20.75 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20.42 | |
| Gilead Sciences, Inc. | 1 | $18.21 | |
| AstraZeneca Pharmaceuticals LP | 1 | $17.06 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
935
Patients
300
Total drug cost
$935,058
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ondansetron Hcl | Generic | 127 | 70 | $4,481 |
| Letrozole | Generic | 106 | 31 | $4,001 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 96 | 20 | $4,125 |
| Gabapentin | Generic | 87 | 22 | $998 |
| Prochlorperazine Maleate | Generic | 81 | 48 | $1,848 |
| Anastrozole | Generic | 74 | 19 | $1,900 |
| Prednisone | Generic | 69 | 39 | $578 |
| Imbruvica (Ibrutinib) | Brand | 62 | 0 | $798,059 |
| Hydroxyurea | Generic | 59 | 15 | $1,729 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 35 | 24 | $671 |